(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.83%) $83.15
(-1.16%) $1.619
(-0.34%) $2 339.30
(0.89%) $27.50
(0.53%) $927.00
(-0.19%) $0.933
(-0.25%) $11.00
(-0.27%) $0.798
(0.00%) $92.17
2 days till quarter result
(bmo 2024-05-01)
Expected move: +/- 5.40%
@ $0.976
发出时间: 8 Feb 2024 @ 04:19
回报率: 29.12%
上一信号: Feb 8 - 02:02
上一信号:
回报率: -0.80 %
Live Chart Being Loaded With Signals
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally...
Stats | |
---|---|
今日成交量 | 1.85M |
平均成交量 | 8.91M |
市值 | 878.21M |
EPS | $0 ( 2024-02-27 ) |
下一个收益日期 | ( $-0.0900 ) 2024-05-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -5.04 |
ATR14 | $0.00700 (0.56%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-28 | Yu Alice Lin-tsing | Buy | 0 | |
2024-03-28 | Paganelli John A | Buy | 0 | |
2024-03-28 | Lachman Prem A | Buy | 0 | |
2024-03-28 | Pfenniger Richard C Jr | Buy | 0 | |
2024-03-28 | Krasno Richard M | Buy | 0 |
INSIDER POWER |
---|
100.00 |
Last 94 transactions |
Buy: 12 318 025 | Sell: 0 |
音量 相关性
OPKO Health Inc 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
OPKO Health Inc 相关性 - 货币/商品
OPKO Health Inc 财务报表
Annual | 2023 |
营收: | $863.50M |
毛利润: | $232.10M (26.88 %) |
EPS: | $-0.250 |
FY | 2023 |
营收: | $863.50M |
毛利润: | $232.10M (26.88 %) |
EPS: | $-0.250 |
FY | 2022 |
营收: | $1.00B |
毛利润: | $288.20M (28.70 %) |
EPS: | $-0.460 |
FY | 2021 |
营收: | $1.77B |
毛利润: | $581.52M (32.77 %) |
EPS: | $-0.0500 |
Financial Reports:
No articles found.
OPKO Health Inc
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units; and a novel diagnostic instrument system to provide blood test results in the point-of-care setting, as well as 4Kscore prostate cancer testing services. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and associated obesity that is in Phase IIb trials; and hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc. This segment develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins. The company also offers specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. In addition, it operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 1991 and is headquartered in Miami, Florida.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。